EDITORIAL
Published on 21 Dec 2022
Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy
doi 10.3389/fimmu.2022.1120207
- 729 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Factors Determining Long Term Anti-Tumor Responses to Immune Checkpoint Blockade Therapy
Factors Determining Long Term Anti-Tumor Responses to Immune Checkpoint Blockade Therapy
29k
Total downloads
83k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 24 Nov 2022
Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors
doi 10.3389/fimmu.2022.880959
- 2,040 views
- 9 citations
ORIGINAL RESEARCH
Published on 25 Oct 2022
The gut microbiota modulates responses to anti–PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors
doi 10.3389/fonc.2022.887383
- 4,347 views
- 12 citations
ORIGINAL RESEARCH
Published on 01 Jul 2022
Artificial Intelligence-Assisted Score Analysis for Predicting the Expression of the Immunotherapy Biomarker PD-L1 in Lung Cancer
doi 10.3389/fimmu.2022.893198
- 5,026 views
- 26 citations
SYSTEMATIC REVIEW
Published on 06 May 2022
Effect of Concomitant Use of Analgesics on Prognosis in Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
doi 10.3389/fimmu.2022.861723
- 2,613 views
- 18 citations
CASE REPORT
Published on 28 Apr 2022
Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma
doi 10.3389/fimmu.2022.870406
- 1,590 views
CASE REPORT
Published on 17 Mar 2022
Case Report: A PD-L1-Positive Patient With Pleomorphic Rhabdomyosarcoma Achieving an Impressive Response to Immunotherapy
doi 10.3389/fimmu.2022.815598
- 1,954 views
- 5 citations
ORIGINAL RESEARCH
Published on 24 Feb 2022
An Immune-Related Gene Pair Index Predicts Clinical Response and Survival Outcome of Immune Checkpoint Inhibitors in Melanoma
doi 10.3389/fimmu.2022.839901
- 1,691 views
- 2 citations
ORIGINAL RESEARCH
Published on 03 Feb 2022
Association of Peripheral Blood Biomarkers With Response to Anti-PD-1 Immunotherapy for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer: A Multicenter Cohort Study
doi 10.3389/fimmu.2022.809971
- 2,739 views
- 16 citations
REVIEW
Published on 11 Jan 2022
Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma
doi 10.3389/fimmu.2021.810388
- 4,201 views
- 15 citations
ORIGINAL RESEARCH
Published on 02 Dec 2021
GDPLichi: a DNA Damage Repair-Related Gene Classifier for Predicting Lung Adenocarcinoma Immune Checkpoint Inhibitors Response
doi 10.3389/fonc.2021.733533
- 2,099 views
- 4 citations
REVIEW
Published on 24 Nov 2021
Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy
doi 10.3389/fimmu.2021.752042
- 4,441 views
- 20 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 83kTopic views
- 53kArticle views
- 29kArticle downloads